glp 1 agonists price in kenya TRULICITY (DULAGLUTIDE) 1.5MG/0.5MG INJECTION 4`S making it suitable for both men and women. GLP-1 Agonists Market Report 2025-2033,

Pre-treatment: Measure morning resting heart rate for 5 days Calculate average baseline Record any existing caffeine or stimulant use During treatment: Measure resting heart rate 3 times weekly during dose escalation Continue at each dose for minimum 4 weeks before increasing If resting HR exceeds baseline by more than 15 BPM, hold dose for an additional 2 weeks If resting HR exceeds 100 BPM at rest on two or more measurements, consult physician Expected timeline: Weeks 1-8: minimal heart rate change at starting doses Weeks 8-24: gradual increase of 5-10 BPM at therapeutic doses Weeks 24+: stabilization and gradual decline toward baseline This is the approach most researchers follow successfully, and it aligns with the standard retatrutide dosing protocol used in clinical trials

doi: 10.1016/j.jdiacomp.2014.01.012 73 BolliGBMunteanuMDotsenkoSNiemoellerEBokaGWuYet al

All three are also indicated for diabetes under different names and dosing schedules, which can be confusing (see the table GLP Agonists for Obesity)

Effect of Intravenous Infusion of Exenatide (Synthetic Exendin-4) on Glucose-Dependent Insulin Secretion and Counterregulation During Hypoglycemia

Pancreatology 16: 2-7, 2016

Koffert J, Honka H, Teuho J, Kauhanen S, Hurme S, Parkkola R, Oikonen V, Mari A, Lindqvist A, Wierup N, et al